Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
USA -Alexion, AstraZeneca’s Rare Disease division has entered into a definitive agreement to acquire LogicBio Therapeutics, in a bid to strengthen the former’s efforts in genomics and rare diseases. AstraZeneca…
Read More
NIGERIA – Medicaid Cancer Foundation (MCF) and pharma giant AstraZeneca, in collaboration with Nigeria’s Federal Ministry of Health, have launched the Project Icon initiative geared towards creating awareness on prostate…
Read More
UK- AstraZeneca’s CEO, Pascal Soriot has announced that the company might not stay in the vaccine industry for very long. He illustrated how swiftly things have changed for the pharmaceutical…
Read More
INDIA- Pharmaceutical company AstraZeneca India has received the go-ahead to market its breast cancer medicine by the Drugs Controller General of India (DCGI). The DCGI has cleared Lynparza (Olaparib) as…
Read More
INDIA- Pharmaceutical giant AstraZeneca India has launched a partnership with respiratory healthcare platform Alveofit to provide IoT-enabled handheld spirometers at hospitals across the nation. This initiative strives to integrate the…
Read More
NIGERIA – The Federal Government of Nigeria (FG) and Population Services International (PSI) Nigeria has entered into a strategic partnership deal with pharma giant AstraZeneca to launch the Healthy Heart…
Read More
KENYA – Kenya’s Ministry of Health has secured digital non-mydriatic research equipment from multinational pharmaceutical company AstraZeneca that uses retinal cameras to analyze the risk of a patient having or…
Read More
UNITED KINGDOM – AstraZeneca is set to acquire US-based biotech company TeneoTwo in a deal worth up to US$1.27bn to boost its pipeline of blood cancer therapies. As part of…
Read More
KENYA – Amref Health Africa, global biopharmaceutical company AstraZeneca and the Ministry of Health in Kenya have partnered to introduce a fleet of Mobile Vaccination Clinics (MVCs) in a bid…
Read More
IRELAND – AstraZeneca has announced that its rare disease group Alexion will invest €65 million (US$68.7M) to scale up its biologics manufacturing capacity and expand R&D efforts at its sites…
Read More